Humanized anti Epiregulin Antibody; vector; host Cell; production method; Pharmaceutical composition that comprises a Therapeutic Agent against cancer; and he understands.
The inventors successfully produced anti-Epiregulin antibodies showing cross-species reactivity between cynomolgus monkey (non-human animals) and human, anti-Epiregulin antibodies with suppressed chemical degradation, anti-Epiregulin antibodies with lowered isoelectric point, anti-Epiregulin antibodies with increased thermal denaturation midpoint temperature, and anti-Epiregulin antibodies with reduced amount of aggregate by performing appropriate amino acid residue substitutions in the variable-region sequences of the humanized EP27 antibody which inhibits growth of cancer cells by exhibiting cytotoxic activity and neutralizing activity against anti-human Epiregulin-expressing cancer cells.ANTICUERPO ANTI-EPIRREGULINA HUMANIZADO; VECTOR; CELULA HUESPED; METODO DE PRODUCCION; COMPOSICION FARMACEUTICA QUE LO COMPRENDE; Y AGENTE TERAPEUTICO CONTRA EL CANCER QUE LO COMPRENDE.